Data / Drug companies / Bachem Americas, Inc.
Bachem Americas, Inc.: 26 products in the FDA NDC directory, labeler code 52416
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Bachem Americas, Inc. (labeler code 52416) lists 26 products in the FDA National Drug Code Directory. By type: 26 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on August 27, 2025.
The request: Watch Bachem Americas, Inc. (FDA labeler code 52416): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52416
- Products in commercial distribution
- 26
- Packages
- 26
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- May 23, 1996
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 14 | 53.8% |
| Bulk ingredients for compounding | 10 | 38.5% |
| Export only | 2 | 7.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 26 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 26 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Liraglutide | 52416-735 | Powder | Bulk ingredients | August 27, 2025 |
| Casimersen | 52416-132 | Powder | Bulk ingredients for compounding | June 2, 2025 |
| Lum015 acetate | 52416-131 | Powder | Bulk ingredients | January 1, 2025 |
| Exenatide | 52416-124 | Powder | Bulk ingredients | November 19, 2024 |
| Golodirsen | 52416-282 | Powder | Bulk ingredients | November 12, 2024 |
| Golodirsen | 52416-133 | Powder | Bulk ingredients | November 12, 2024 |
| Casimersen | 52416-134 | Powder | Bulk ingredients for compounding | January 2, 2024 |
| Avi-4658 | 52416-130 | Powder | Bulk ingredients | February 18, 2022 |
| Casimersen | 52416-129 | Powder | Bulk ingredients for compounding | February 25, 2021 |
| Casimersen | 52416-095 | Powder | Bulk ingredients for compounding | February 25, 2021 |
| Teriparatide acetate (hpth (1-34)) | 52416-126 | Powder | Export only | December 22, 2020 |
| Octreotide acetate | 52416-123 | Powder | Bulk ingredients for compounding | June 26, 2020 |
| Golodirsen | 52416-128 | Powder | Bulk ingredients | December 12, 2019 |
| Avi-4658 250l | 52416-798 | Powder | Bulk ingredients for compounding | July 10, 2019 |
| Avi-4658 50l | 52416-640 | Powder | Bulk ingredients for compounding | May 20, 2019 |
| Vasopressin | 52416-127 | Powder | Bulk ingredients for compounding | May 16, 2019 |
| Octreotide | 52416-109 | Powder | Bulk ingredients | April 6, 2018 |
| Ziconotide | 52416-777 | Powder | Bulk ingredients for compounding | November 21, 2017 |
| Avi-4658 | 52416-120 | Powder | Bulk ingredients for compounding | September 30, 2015 |
| Hexenoyl-hgrf 1-44 | 52416-107 | Powder | Bulk ingredients | November 10, 2010 |
| Calcitonin salmon | 52416-111 | Powder | Bulk ingredients | June 8, 2009 |
| Pramlintide | 52416-106 | Powder | Bulk ingredients | May 16, 2005 |
| Exenatide | 52416-105 | Powder | Bulk ingredients | April 28, 2005 |
| Deslorelin | 52416-110 | Powder | Bulk ingredients | November 19, 2003 |
| Desmopressin | 52416-108 | Powder | Export only | September 27, 2001 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.